NewsNation covers early signs that pairing a GLP-1 drug with other treatment could bring added benefits for people with psoriasis.
Recap by typeshit. Full story at NewsNation.
A Facebook post says US researchers found pancreatic cells producing GLP-1 on their own. It frames this as a possible built-in appetite and sugar control system, without naming the study.
Researchers are studying whether GLP-1 drugs, which act on mood, appetite and reward pathways, could help with depression, addiction and binge eating.
A retrospective cohort checks whether retinal disease started or worsened more in established users than in people never on either drug, plus a regional NAION review.
24:34
An animated explainer walking through what semaglutide does in the body, from appetite signals in the brain to digestion and blood sugar control.
The new Huberman Lab episode covers how food choices affect memory and cravings, including the body's own GLP-1, the drugs, and microdosing.
The company says the application also covers cells producing GLP-2 and other therapeutic peptides, framing it as a platform rather than one drug.
Loading…